Soothes itching. Reduces dryness.
Soothes - Hydrates
Soothes itching* in psoriasis-prone skin.
The KERTYOL PSO Daily hydrating balm broadly cares for psoriasis-prone skin, including the areas of the skin covered in plaques and those without.
This anti-itch balm soothes itching* and helps to limit the appearance of new plaques.
Its formula contains active ingredients specifically CELASTROL is a revolutionary soothing active ingredient that directly targets keratinocytes (cells in the superficial layer of the skin) to reduce the appearance of the plaques and thus improve the appearance of the skin.
POLIDOCANOL helps to relieve itching* and, therefore, to reduce scratching, which usually causes new flare-ups.
47%* less skin dryness after eight days of use. 52%* fewer itching sensations** after one month of use.
• REDUCES skin dryness : the skin is less dry and more comfortable
• SOOTHES itching* : POLIDOCANOL helps calm the itching caused by skin dryness
• IMPROVES the appearance of the skin : acts directly on the keratinocytes (cells of the superficial layer of skin) to reduce the appearance of plaques and thus improve the appearance of the skin
*Itching caused by skin dryness
**Itching caused by skin dryness
• Apply once a day to the entire body.
• Can be used in combination with or as a follow up to medical treatments.
Precaution to use :
• Avoid contact with eyes.
• It has been specifically formulated to take care of all of the skin, beyond the plaques.
• Recent publications show that only by taking care of the whole of your skin daily can you limit the reappearance of plaques.
Active ingredient that soothes itching sensations* *Caused by skin dryness.
1st innovative active ingredient from Pierre Fabre biotechnology, Celastrol, is of 100% natural origin and produced through the cultivation of plant cells. This soothing active ingredient directly targets keratinocytes to reduce the appearance of plaques and improve skin appearance
• -47% skin dryness after 8 days of use¹
• -59% itching* from 1 month¹
¹Perceived clinical efficacy evaluated in 41 subjects with mild to moderate psoriasis on the body. 1 application/day for 4 weeks.
